What Happens After You Start Using an Automated Insulin Pump? A Study of Real-World Outcomes in Young People

Automated insulin delivery (AID) systems—often called hybrid closed-loop pumps—have become an important tool for managing Type 1 diabetes. These devices use continuous glucose monitors and automated algorithms to deliver insulin without constant manual input. But while we know AID systems help many people, we don't fully understand which young people benefit most or how their blood sugar control changes over time.

Researchers studied 713 youth ages 6 to 18 who started using AID systems, tracking their blood sugar control over 18 months. The goal was to understand the different patterns that emerge and what factors predict who reaches the best outcomes.

The clearest finding: everyone improved fast once they started. From the beginning through the first three months, all youth saw rapid improvements in both time in range (TIR)—the percentage of time blood sugar stayed in target—and HbA1c, a measure of average blood sugar over three months.

After three months, improvement continued but at a slower pace through the six-month mark. Beyond six months, the benefits either stayed steady or began to decline, depending on the group. This pattern held across all the different trajectories researchers identified.

The study identified four distinct patterns in how time in range changed over the 18-month period, and three patterns for HbA1c. The most striking finding: only 12.7% of youth achieved the ideal time-in-range target of 70% or higher. However, a much larger group—43.3%—reached an HbA1c below 7%, which is a meaningful blood sugar goal.

This shows that different measures of blood sugar control tell different stories. Some young people may reach HbA1c targets but not sustain high time in range, and the reasons why matter for tailoring support.

Researchers looked for predictors of who ended up in the best-performing group versus the lowest-performing group for time in range. They adjusted for age, sex, how long someone had Type 1 diabetes, and what treatment they used before starting AID.

Young people who used fewer manual boluses (insulin doses you give yourself outside the system's automatic delivery), required higher doses of insulin per kilogram of body weight, and had fewer appointments with their diabetes care team were more likely to fall into the lowest time-in-range group. In other words, less active engagement with the system and fewer clinical visits were associated with worse outcomes.

For HbA1c specifically, starting with lower insulin doses and giving more manual boluses pointed toward better results. This suggests that how and how often someone interacts with their AID system from the beginning shapes their long-term trajectory.

This research underscores that starting an automated insulin pump is not a 'set it and forget it' solution. Early improvements are encouraging, but sustaining them requires ongoing engagement with the technology and regular contact with your diabetes care team.

The findings highlight the importance of learning to use your AID system actively—including when and how to give manual boluses—rather than relying solely on automation. Regular clinic visits also appear to play a real role in helping young people stay on an optimal trajectory.

If your child or teen uses an AID system, this study reinforces why appointments, training, and troubleshooting with your care team matter just as much after those first few months as they do at the start.

Source: Diabetes care. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.